These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11417114)

  • 1. Anti-influenza drugs and neuraminidase inhibitors.
    Roberts NA
    Prog Drug Res; 2001; 56():195-237. PubMed ID: 11417114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-influenza drugs and neuraminidase inhibitors.
    Roberts NA
    Prog Drug Res; 2001; Spec No():35-77. PubMed ID: 11548210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sialidase activity as a therapeutic approach.
    Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
    Drug Des Devel Ther; 2018; 12():3431-3437. PubMed ID: 30349196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
    Hurt AC; Ho HT; Barr I
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress of neuraminidase inhibitors for anti-influenza].
    Liu AL; Wang HD; Yang F; Du GH
    Yao Xue Xue Bao; 2009 Sep; 44(9):935-42. PubMed ID: 20055166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitors: progress in the management of influenza.
    Woodhead M; Lavanchy D; Johnston S; Colman P; Fleming D
    Int J Clin Pract; 2000 Nov; 54(9):604-10. PubMed ID: 11220989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the structure-based design of the influenza A neuraminidase inhibitors.
    Mitrasinovic PM
    Curr Drug Targets; 2010 Mar; 11(3):315-26. PubMed ID: 20210756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medicinal potential of influenza virus surface proteins: hemagglutinin and neuraminidase.
    Xie Y; Gong J; Li M; Fang H; Xu W
    Curr Med Chem; 2011; 18(7):1050-66. PubMed ID: 21254972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Critical review of anti-influenza drugs].
    van Loon FP; Voordouw AC; Simonian S; Koopmans PP
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):165-7. PubMed ID: 10668542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study.
    Dobrovolny HM; Gieschke R; Davies BE; Jumbe NL; Beauchemin CA
    J Theor Biol; 2011 Jan; 269(1):234-44. PubMed ID: 20970433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza.
    Young D; Fowler C; Bush K
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1905-13. PubMed ID: 11779391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.
    Shan Y; Ma Y; Wang M; Dong Y
    Curr Med Chem; 2012; 19(34):5885-94. PubMed ID: 22963668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza.
    Dreitlein WB; Maratos J; Brocavich J
    Clin Ther; 2001 Mar; 23(3):327-55. PubMed ID: 11318072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
    Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-influenza drugs: the development of sialidase inhibitors.
    von Itzstein M; Thomson R
    Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of neuraminidase inhibitors to combat pandemic influenza.
    Democratis J; Pareek M; Stephenson I
    J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.